Oldest pages
Showing below up to 159 results in range #51 to #209.
- TCRγδ (21:28, 14 May 2023)
- HLA-DR (18:36, 16 May 2023)
- CD11b (17:31, 27 May 2023)
- CD15 (09:57, 30 May 2023)
- CD16 (14:29, 31 May 2023)
- IgM (12:57, 1 June 2023)
- CD24 (18:32, 7 June 2023)
- CD56 (13:20, 8 June 2023)
- CD57 (16:15, 11 June 2023)
- CD61 (23:01, 11 June 2023)
- Extra (20:53, 13 June 2023)
- CD3 (11:22, 14 June 2023)
- CD65 (15:26, 14 June 2023)
- CD235 (15:29, 14 June 2023)
- Key to marker expression table (21:00, 17 June 2023)
- CD2 (22:36, 17 June 2023)
- Monoclonal B lymphocytosis (22:26, 18 June 2023)
- Test open (11:43, 19 June 2023)
- Flow cytometric marker pattern of mantle cell lymphoma (12:53, 20 June 2023)
- Flow cytometric marker pattern of chronic lymphocytic leukaemia (23:44, 20 June 2023)
- NEW (12:33, 21 June 2023)
- Detailed description of individual markers used in diagnosis (14:37, 28 June 2023)
- Immunoglobulin light chains (21:31, 4 July 2023)
- FMC7 (21:33, 4 July 2023)
- TDT (21:34, 4 July 2023)
- MPO (21:34, 4 July 2023)
- CD5 (21:36, 4 July 2023)
- CD10 (21:36, 4 July 2023)
- CD13 (21:37, 4 July 2023)
- CD14 (21:38, 4 July 2023)
- CD19 (21:38, 4 July 2023)
- CD22 (21:39, 4 July 2023)
- CD23 (21:40, 4 July 2023)
- CD25 (21:42, 4 July 2023)
- CD34 (21:43, 4 July 2023)
- CD38 (21:43, 4 July 2023)
- CD79a (21:44, 4 July 2023)
- CD79b (21:45, 4 July 2023)
- CD103 (21:45, 4 July 2023)
- CD117 (21:46, 4 July 2023)
- CD138 (21:47, 4 July 2023)
- CD200 (21:47, 4 July 2023)
- Alt (11:33, 6 July 2023)
- CD20 (13:58, 6 July 2023)
- Alt Alt (11:26, 10 July 2023)
- Summary tables comparing neoplastic disorders (11:29, 10 July 2023)
- Description of individual markers (10:23, 11 July 2023)
- Expression strength key (16:14, 11 July 2023)
- Flow cytometry: Mantle cell Lymphoma (16:18, 11 July 2023)
- Description of marker expression of specific disorders (14:21, 12 July 2023)
- CD45 (16:56, 13 July 2023)
- Flow cytometry: Chronic Lymphocytic leukaemia (17:11, 13 July 2023)
- Flow cytometry: Mantle Cell Lymphoma (17:16, 13 July 2023)
- Flow cytometry: Follicular Lymphoma (17:17, 13 July 2023)
- Flow cytometry: Marginal Zone Lymphoma (17:18, 13 July 2023)
- Flow cytometry: Hairy Cell Leukaemia (17:19, 13 July 2023)
- Flow cytometry: Diffuse Large B-cell Lymphoma (17:22, 13 July 2023)
- Flow cytomtery: Lymphoplasmacytic lymphoma (16:05, 14 July 2023)
- Flow cytometry: Lymphoplasmacytic Lymphoma (16:08, 14 July 2023)
- CD11c (16:29, 14 July 2023)
- Test (18:09, 14 July 2023)
- Marker expression in B-lymphoproliferative disorders (18:10, 14 July 2023)
- Flow cytometry: Plasma cells (18:10, 14 July 2023)
- Marker Tables: B-lymphoproliferative disorders (18:24, 14 July 2023)
- CD33 (15:43, 17 July 2023)
- ALT (09:55, 28 July 2023)
- Image Index of red cell forms (11:48, 2 October 2023)
- Important elements in acute myeloid leukaemia diagnosis (18:14, 5 October 2023)
- Main Page (12:39, 6 October 2023)
- CD64 (09:43, 12 October 2023)
- CD-classified flow cytometry markers (11:07, 16 October 2023)
- CD36 (12:36, 17 October 2023)
- CD71 (12:50, 17 October 2023)
- Non CD-classified flow cytometry markers markers (12:51, 20 October 2023)
- MPAL (12:00, 27 November 2023)
- Acute leukaemia types (16:52, 28 November 2023)
- Table (14:13, 11 December 2023)
- Atypical patterns of primitive marker expression in acute leukaemia (18:57, 11 December 2023)
- Immnophenotypic markers in AML (12:23, 21 December 2023)
- AUL (11:27, 22 December 2023)
- Flow Ctrometry:B-lymphoid lineage assignment (14:26, 22 December 2023)
- Flow Cytometry (19:04, 22 December 2023)
- Flow cytometry:Acute Leukaemia of ambiguous lineage not otherwise sepcified (19:11, 22 December 2023)
- Flow cytometry:ALAL-NOS (15:11, 31 December 2023)
- BPDCN (13:59, 2 January 2024)
- ETP-ALL (13:16, 4 January 2024)
- Tables of diagnostic patterns associated with aberrancy or alternative diagnosis in AML (13:28, 5 January 2024)
- Tables of diagnostic markers supporting assignment of primitive phenotype in AML (13:49, 5 January 2024)
- Myeloid lineage-associated markers (19:57, 5 January 2024)
- Myeloid lineage-defining markers (19:58, 5 January 2024)
- Flow Cytometry:B-lymphoid lineage assignment (20:19, 5 January 2024)
- Flow Cytometry:T-Lymphoid lineage assignment (20:22, 5 January 2024)
- Flow Cytometry:Myeloid lineage assignment (19:59, 8 January 2024)
- Flow Cytometry:Myeloid lineage assignment in MPAL (12:43, 9 January 2024)
- Flow Cytometry:B-lymphoid lineage assignment in MPAL (12:47, 9 January 2024)
- Flow Cytometry:T-Lymphoid lineage assignment in MPAL (15:28, 9 January 2024)
- Tables of diagnostic markers supporting lineage assignment in AML (11:48, 11 January 2024)
- Recognition of APL differentiation (00:15, 12 January 2024)
- Additional immunophenotypic markers useful in lineage assignment or subtyping of AML (14:19, 12 January 2024)
- CD123 (14:43, 12 January 2024)
- Flow cytometry:BPDCN (14:45, 12 January 2024)
- Table of frequent aberrant markers in AML (17:26, 12 January 2024)
- Flow cytometry: Myeoid-defining markers (19:51, 13 January 2024)
- Flow cytometry: Myeloid-defining markers (19:54, 13 January 2024)
- Flow cytometry:ETP-ALL (17:21, 17 January 2024)
- Flow cytometry:MPAL (13:34, 18 January 2024)
- Flow cytometry:AUL (14:01, 18 January 2024)
- Marker patterns of other AML-related differentiation (20:06, 30 January 2024)
- Marker patterns erythroid or megakaryocyte differentiation (12:43, 2 February 2024)
- Markers used to demonstrate primitive nature in AML (19:09, 2 February 2024)
- Recognition of blast cells with monocytic differentiation (19:14, 2 February 2024)
- Atypical patterns of primitive marker expression in acute myeloid leukaemia (19:16, 2 February 2024)
- ''P.falciparum'' gallery (15:35, 5 March 2024)
- Red Cell Menu (20:43, 9 March 2024)
- ''Plasmodium falciparum'': Morphology (12:43, 14 March 2024)
- Trophozoites: diagnostic guide (16:58, 14 March 2024)
- The flow cytometric diagnosis of AML (15:28, 15 March 2024)
- Species Identification (20:36, 17 March 2024)
- Ring forms (22:04, 18 March 2024)
- Multiple parasites (22:04, 18 March 2024)
- Accolé form (13:17, 19 March 2024)
- Double chromatin dot forms (13:19, 19 March 2024)
- Malaria stage recognition (16:23, 19 March 2024)
- P.falciparum early trophozoites gallery (12:18, 20 March 2024)
- P.falciparum late trophozoites gallery (00:30, 21 March 2024)
- P.falciparum schizont gallery (10:48, 21 March 2024)
- P.falciparum gametocyte gallery (11:01, 21 March 2024)
- Stained correctly (12:33, 24 March 2024)
- Red cell size (22:13, 24 March 2024)
- Maurer's dots and clefts (11:36, 25 March 2024)
- Malaria Index (20:11, 27 March 2024)
- Schizont Development (20:22, 27 March 2024)
- Malaria pigment (15:26, 28 March 2024)
- Banana gametocyte (12:45, 30 March 2024)
- Red cell size and shape: P.vivax (17:56, 2 April 2024)
- Alaphatical list of specific malaria features (17:58, 2 April 2024)
- General features of red cell size and shape in malaria (17:59, 2 April 2024)
- Red cell size and shape (18:04, 2 April 2024)
- Schüffner's dots (13:44, 3 April 2024)
- P.vivax late trophozoites gallery (11:10, 4 April 2024)
- P.vivax early trophozoites gallery (11:12, 4 April 2024)
- Amoeboid (17:54, 4 April 2024)
- P.vivx schizont gallery (21:01, 7 April 2024)
- P.vivax gametocyte gallery (21:02, 7 April 2024)
- P.vivax schizont gallery (11:06, 8 April 2024)
- Plasmodium vivax: Morphology (14:17, 11 April 2024)
- Click for images of schizont morphology (18:24, 17 April 2024)
- Biology of the schizont (14:07, 18 April 2024)
- Pre-erythrocytic (liver) stage (11:01, 22 April 2024)
- Overview of malaria biology (17:16, 25 April 2024)
- Storage changes in malaria (13:31, 29 April 2024)
- Malaria Biology (09:29, 30 April 2024)
- Morphology of the sexual phase of parasite development (12:15, 1 May 2024)
- Re-infection of the mosquito (12:16, 1 May 2024)
- Images of gametocyte development in stored blood (12:19, 1 May 2024)
- Species identification: summary page (14:26, 1 May 2024)
- Plasmodium ovale: Morphology (10:24, 2 May 2024)
- Plasmodium falciparum: Morphology (10:27, 2 May 2024)
- P.ovale early trophozoites gallery (11:12, 2 May 2024)